For Chemours Company [CC], Analyst sees a rise to $19. What next?

KRBP

Chemours Company [NYSE: CC] stock went on an upward path that rose over 2.42% on Wednesday, amounting to a one-week price decrease of less than -7.33%.

Over the last 12 months, CC stock dropped by -54.88%. The one-year Chemours Company stock forecast points to a potential upside of 27.63. The average equity rating for CC stock is currently 2.00, trading closer to a bullish pattern in the stock market.

The market cap for the stock reached $1.65 billion, with 149.57 million shares outstanding and 148.55 million shares in the current float. Compared to the average trading volume of 3.89M shares, CC stock reached a trading volume of 6345182 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Guru’s Opinion on Chemours Company [CC]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CC shares is $15.20 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CC stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Mizuho have made an estimate for Chemours Company shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on March 27, 2025. While these analysts kept the previous recommendation, Truist raised their target price to Buy. The new note on the price target was released on January 28, 2025, representing the official price target for Chemours Company stock. Previously, the target price had yet another raise from $28 to $30, while UBS kept a Buy rating on CC stock.

The Average True Range (ATR) for Chemours Company is set at 0.63, with the Price to Sales ratio for CC stock in the period of the last 12 months amounting to 0.28. The Price to Book ratio for the last quarter was 2.84, with the Price to Cash per share for the same quarter was set at 3.10.

CC Stock Performance Analysis:

Chemours Company [CC] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -7.33. With this latest performance, CC shares dropped by -1.61% in over the last four-week period, additionally sinking by -42.23% over the last 6 months – not to mention a drop of -54.88% in the past year of trading.

Insight into Chemours Company Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and Chemours Company [CC] shares currently have an operating margin of 7.41% and a Gross Margin at 19.03%. Chemours Company’s Net Margin is presently recorded at 0.53%.

Return on Equity for this stock inclined to 0.40%, with Return on Assets sitting at 0.40%.

CC Stock EPS

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CC. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Chemours Company go to 33.04%.

Chemours Company [CC] Institutonal Ownership Details

There are presently around $98.02%, or 98.47%% of CC stock, in the hands of institutional investors. The top three institutional holders of CC stocks are: FMR LLC with ownership of 17.52 million shares, which is approximately 11.7284%. BLACKROCK INC., holding 16.26 million shares of the stock with an approximate value of $$366.98 million in CC stocks shares; and BLACKROCK INC., currently with $$342.23 million in CC stock with ownership which is approximately 10.1483%.

The DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.